WISeKey Logo.png
WISeKey International Holding Ltd Receives Extension of the Deadline for the Publication of its FY 2023 Annual Report and Releases Unaudited FY 2023 Key Metrics
April 30, 2024 01:00 ET | Wisekey International Holding Ltd.
Zug, Switzerland, April 30, 2024 (GLOBE NEWSWIRE) -- Also Files Form 12b-25 with SEC Related to Annual Report on Form 20-F Ad hoc announcement pursuant to Art. 53 of SIX Listing Rules – WISeKey...
Logo- Jiayin Group.jpg
Jiayin Group Inc. Filed Annual Report on Form 20-F for Fiscal Year 2023
April 29, 2024 22:30 ET | Jiayin Group Inc.
SHANGHAI, China, April 29, 2024 (GLOBE NEWSWIRE) -- Jiayin Group Inc. (“Jiayin” or the “Company”) (NASDAQ: JFIN), a leading fintech platform in China, today announced that it has filed its annual...
mesologo.png
Appendix 4c Quarterly Activity Report for Quarter Ended March 31, 2024
April 29, 2024 21:05 ET | Mesoblast Limited
NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an activity report for...
foremost logo in banner.png
Foremost Lithium Announces Closing of the Second Tranche of its Flow-Through Private Placement for Gross Proceeds of $1.455M
April 29, 2024 21:00 ET | Foremost Lithium Resource & Technology Ltd.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, April 29, 2024 (GLOBE NEWSWIRE) -- Foremost Lithium Resource &...
MustangBioLogo.jpg
Mustang Bio Announces Pricing of $4 Million Public Offering
April 29, 2024 20:00 ET | Mustang Bio, Inc.
WORCESTER, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical...
Unknown.png
TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering
April 29, 2024 20:00 ET | TFF Pharmaceuticals, Inc.
FORT WORTH, Texas, April 29, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”), a clinical-stage biopharmaceutical company focused on...
Sound Financial Bancorp logo
Sound Financial Bancorp, Inc. Q1 2024 Results
April 29, 2024 19:34 ET | Sound Financial Bancorp, Inc.
SEATTLE, April 29, 2024 (GLOBE NEWSWIRE) -- Sound Financial Bancorp, Inc. (the "Company") (Nasdaq: SFBC), the holding company for Sound Community Bank (the "Bank"), today reported net income of $770...
Relativity Acquisition Corp. Announces Receipt of Nasdaq Delisting Determination
April 29, 2024 19:16 ET | Relativity Acquisition Corp.
NEW YORK, NY,, April 29, 2024 (GLOBE NEWSWIRE) -- Relativity Acquisition Corp. (Nasdaq: RACY) (the “Company”) today announced that, on April 23, 2024, the Company received a determination letter...
MercadoLibre, Inc. Logo
MercadoLibre, Inc. to Report First Quarter 2024 Financial Results
April 29, 2024 18:31 ET | MercadoLibre, Inc.
Montevideo, April 29, 2024 (GLOBE NEWSWIRE) --   MercadoLibre, Inc. to Report First Quarter 2024 Financial Results MONTEVIDEO, Uruguay; April 29, 2024; (GLOBE NEWSWIRE) -- MercadoLibre, Inc....
Rhythm_Logo_RGB_JPG-registration mark.jpg
Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology
April 29, 2024 18:30 ET | Rhythm Pharmaceuticals, Inc.
- Publication highlights administration of setmelanotide therapy resulted in a mean percent reduction in BMI of 15% at 16 weeks and 26% at one year of treatment - - Topline data from ongoing pivotal...